Free webinar on pluripotent stem cells
Lonza has announced that it is holding a free webinar, titled ‘Pluripotent Stem Cells - From Research to Therapy’, on 17 June. The webinar is aimed at helping researchers streamline pluripotent stem cells (PSC) workflow through various stages of research and development.
PSCs have the ability to generate all 220+ cell types found within the human body, meaning they offer great potential for basic research, drug discovery and cell replacement therapies. However, Lonza has uncovered the need for a wide range of tools and educational materials to support those working with PSCs in order to help solve a number of technical challenges.
To be hosted by Lonza scientific support specialists, the webinar will cover the following:
- Technical challenges of induced pluripotent stem cell (iPSC)-based therapies
- General considerations for iPSC researchers with clinical aspirations
- The L7 hiPSC Reprogramming Bundle for the generation of peripheral blood mononuclear cell (PBMC)-derived iPSCs
- The L7 hPSC Culture System for xeno-free, defined culturing of human pluripotent stem cells (hPSCs)
- Application examples
- A live Q&A session
Interested parties can register to attend the webinar by selecting their preferred time below:
Those interested in the topic but unable to join the webinar are invited to visit Lonza’s online archive to access the content at a later date.
Virologist receives GSK Award for AI-based disease detection
Professor Edward Holmes has received the 2025 GSK Award for Research Excellence for his...
WA Govt creates Science and Technology Council
The council will offer independent advice on emerging opportunities and challenges, promoting...
Billion-dollar deal for UQ's molecular clamp vaccine tech
Sanofi has entered into an agreement to acquire Vicebio, a biotech company formed in 2018 to...